Nuvalent
Chad Nagel, CPA, CFE, is a highly accomplished finance professional with extensive experience in revenue accounting and government pricing across multiple organizations. Currently serving as Senior Director of Revenue Accounting at Nuvalent, Inc. since May 2025, previous roles include Senior Director of Revenue Management at Milestone Pharmaceuticals, Executive Director of Revenue Accounting & Government Pricing at Marinus Pharma, and Senior Director at Optinose. Chad's expertise includes developing forecasting models, overseeing government pricing calculations, managing rebate processing, and providing strategic financial analysis to commercial teams. Academic qualifications include a Master of Science in Accountancy from The Graduate School of the College of Charleston and a Bachelor of Science in Business Administration with a focus on Accounting from the University of South Carolina Upstate.
This person is not in any teams
This person is not in any offices
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.